HSPG2 and type 2 diabetes mellitus: It can thus be plausibly hypothesized that, because concentrations of circulating glucagon in T2D remain within zone 1 (Figure 2c), glucagon’s contribution to elevations in hepatic glucose output, and thus to the hyperglycemia, in T2D would be mediated exclusively by the PLC/IP3 pathway in vivo.